Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

NCT00240409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Pramipexole
DRUG: Bromocriptine

Sponsor

Boehringer Ingelheim